Aflac (NYSE:AFL) Price Target Raised to $98.00

Aflac (NYSE:AFL - Get Free Report) had its price target upped by equities research analysts at Barclays from $96.00 to $98.00 in a research note issued on Monday,Benzinga reports. The firm presently has an "underweight" rating on the financial services provider's stock. Barclays's price target would indicate a potential downside of 3.51% from the company's current price.

Several other equities research analysts also recently weighed in on the company. Truist Financial upped their price target on Aflac from $100.00 to $105.00 and gave the stock a "hold" rating in a report on Friday, November 1st. JPMorgan Chase & Co. lifted their price target on shares of Aflac from $85.00 to $90.00 and gave the stock a "neutral" rating in a research note on Thursday, October 3rd. Wells Fargo & Company raised their price objective on shares of Aflac to $107.00 and gave the company a "hold" rating in a report on Tuesday, December 3rd. TD Cowen began coverage on shares of Aflac in a research note on Wednesday, October 9th. They set a "hold" rating and a $102.00 target price for the company. Finally, Piper Sandler lifted their price target on Aflac from $114.00 to $122.00 and gave the stock an "overweight" rating in a report on Wednesday, October 2nd. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, Aflac has a consensus rating of "Hold" and an average target price of $98.87.

Aflac Trading Down 1.6 %

NYSE:AFL traded down $1.60 on Monday, reaching $101.56. 1,903,007 shares of the company's stock were exchanged, compared to its average volume of 1,657,536. The business has a fifty day moving average of $107.01 and a 200-day moving average of $104.57. The company has a quick ratio of 0.08, a current ratio of 0.08 and a debt-to-equity ratio of 0.32. Aflac has a 52-week low of $75.07 and a 52-week high of $115.50. The firm has a market capitalization of $56.42 billion, a price-to-earnings ratio of 15.30, a price-to-earnings-growth ratio of 2.09 and a beta of 1.00.

Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.69 by $0.47. The company had revenue of $2.95 billion for the quarter, compared to analyst estimates of $4.30 billion. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The firm's quarterly revenue was down 40.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.84 EPS. As a group, analysts expect that Aflac will post 7.27 earnings per share for the current year.

Insider Activity at Aflac

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the company's stock in a transaction on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now owns 222,618 shares in the company, valued at approximately $23,018,701.20. This represents a 10.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.90% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. TD Asset Management Inc lifted its holdings in shares of Aflac by 2.1% in the 2nd quarter. TD Asset Management Inc now owns 188,370 shares of the financial services provider's stock valued at $16,823,000 after buying an additional 3,861 shares during the period. Private Advisor Group LLC grew its stake in shares of Aflac by 11.5% during the 2nd quarter. Private Advisor Group LLC now owns 18,037 shares of the financial services provider's stock worth $1,611,000 after purchasing an additional 1,862 shares during the period. Candriam S.C.A. increased its holdings in shares of Aflac by 5.3% in the 2nd quarter. Candriam S.C.A. now owns 35,415 shares of the financial services provider's stock valued at $3,163,000 after purchasing an additional 1,772 shares in the last quarter. Savant Capital LLC lifted its stake in shares of Aflac by 28.8% in the second quarter. Savant Capital LLC now owns 11,842 shares of the financial services provider's stock valued at $1,058,000 after purchasing an additional 2,647 shares during the period. Finally, Strategic Financial Concepts LLC boosted its holdings in Aflac by 7,001.0% during the second quarter. Strategic Financial Concepts LLC now owns 667,706 shares of the financial services provider's stock worth $596,000 after buying an additional 658,303 shares in the last quarter. 67.44% of the stock is owned by hedge funds and other institutional investors.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.